All articles by Srivani Venna

Srivani Venna

Boston Scientific reports initial data from ACURATE neo2 system study

Another observation from the study was a low 6.5% rate of new pacemaker implantation 30 days after procedures.

Washington University School of Medicine finds biomarker to identify CBD

Sato and Kanta Horie and colleagues used a technique to look for different forms of tau linked to primary tauopathies.

Roche unveils new rapid antibody test for use by healthcare professionals

The test has a 95.83% sensitivity and 100% specificity when performed at least 15 days after symptom onset.

Pillar Biosciences’ colon cancer assay obtains approval from China NMPA

The oncoReveal Dx Colon Cancer Assay generates data by using the company’s sensitive SLIMamp NGS testing technology.

BioFluidica reports positive data from liquid biopsy platform trial

The findings obtained from the study were more favourable when compared with those obtained from needle biopsy.

Indica Labs receives CE-IVD Mark for prostate cancer screening tool

The study was conducted on 4,973 core needle biopsies obtained from three independent arms.

Illumina adds new CDx indication to TruSight Oncology test

The TSO Comprehensive (EU) test uses a single biopsy specimen to combine less and more prevalent biomarkers.

UAMS commences acetaminophen toxicity rapid diagnostic test study

The AcetaSTAT rapid assay can detect blood markers for injury from an overdose of the drug in about 20 minutes.

LumiraDx Covid-19 antigen assay receives Emergency Use Listing by WHO

The LumiraDx SARS-CoV-2 Ag Test joins a select group of antigen tests included in the WHO EUL.

Vibrant Gastro reports positive data from drug-free CIC treatment trial

The Vibrant System has been validated as a safe and well-tolerated option for addressing unmet treatment needs in CIC.